| Application no. and date | 20729951.2 (espacenet) (Federated) (European Patent Register), 20200508 | | Patent/reg. no. and date | DK/EP 4058148, 20240313 | | Publication date | 20220921 | | Priority no. and date | EP 19208417, 20191111 | | EP pub. no. and date |
EP 4058148 20220921 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, California 91320-1799, US,
Amgen Research (Munich) GmbH, Staffelseestrasse 2
81477 München, DE | | Applicant ref. no. | 1694885 | | Inventor | STIEGLMAIER, Julia, c/o Amgen Research (Munich) GmbH
Staffelseestrasse 2
81477 Muenchen, DE,
HUBER, Birgit, c/o Amgen Research (Munich) GmbH
Staffelseestrasse 2
81477 Muenchen, DE,
UPRETI, Vijay, c/o Amgen Inc. One Amgen Center Drive
Thousand Oaks, California 91320, US,
MINELLA, Alexander, c/o Amgen Inc.
One Amgen Center Drive
Thousand Oaks, California 91320, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | DOSERINGSREGIME FOR ANTI-BCMA-MIDLER | | Int. application no. | EP2020062876 | | Int. publication no. | WO2021094000 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
